JLJoão Lemos

João Lemos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


João Lemos has a total of 249 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Traumatismo Crânio-Encefálico Ligeiro: Recomendações Clínicas de Consenso Nacional

    by Filipa Ferreira, Armando Lopes, Carla Freitas, Carolina Domingues, Helena Silva, Inês Nunes, João Lemos, Jorge Pereira, José Luís Alves, Adelina Pereira

    O traumatismo crânio-encefálico ligeiro representa globalmente cerca de 80% dos traumas de crânio. Apesar da sua aparente benignidade, existem custos e sequelas elevados. A avaliação das vítimas deve seguir uma lógica de estratificação de gravidade para a decisão da abordagem subsequente. O uso sistemático da tomografia é consensual como ferramenta de diagnóstico nos casos moderados ou graves, mas permanece controverso nos casos ligeiros. Nos últimos anos, os biomarcadores séricos emergem como uma ferramenta objetiva e complementar na estratificação do risco de lesão. A proteína ácida fibrilar glial e a ubiquitina C-terminal hidrolase L1 auxiliam a tomada de decisão em doentes com escala de coma de Glasgow entre 14 e 15 nas primeiras 12 horas após trauma. Neste consenso, pretende-se estabelecer um algoritmo de decisão baseado na conjugação de scores clínicos como o Canadian CT Head Rule (elevada sensibilidade) e biomarcadores. O algoritmo tem como principal objetivo homogeneizar a abordagem, baseando-se na evidência e procurando reduzir a exposição a radiações e a permanência no serviço de urgência, promovendo, em simultâneo, altas com segurança clínica. Nos casos de risco moderado, quando a proteína ácida fibrilar glial e a ubiquitina C-terminal hidrolase L1 são negativas nas primeiras 12 h após trauma, a necessidade de tomografia computorizada crânio-encefálica é excluída pelo elevado valor preditivo negativo destes biomarcadores, permitindo a alta salvo outra indicação clínica. Todos os doentes de alto risco farão tomografia computorizada crânio-encefálica, os sob terapêutica antitrombótica adicionalmente biomarcadores: ambos resultados negativos permitem considerar alta; ambos resultados positivos implicam admissão, se tomografia computorizada negativa e pelo menos um dos biomarcadores positivo sugere-se: repetição da tomografia computorizada crânio-encefálica em doentes com idade igual ou superior a 75 anos, em virtude de valores elevados séricos mesmo na ausência de trauma em 95% deste subgrupo e da inexistência à data de cut-offs ajustados à idade; devem repetir-se biomarcadores se idade inferior a 75 anos. Pretende-se ainda dar a conhecer uma nova proposta de classificação do traumatismo crânio-encefálico que visa uma caracterização mais completa e individualizada.

  • Papilledema and related clinical and paraclinical visual assessment in cerebral venous and sinus thrombosis versus idiopathic intracranial hypertension

    by Ana Inês Martins, André Jorge, Sara Matos, Diogo Damas, Liliana Silva, Inês Pais, Beatriz Silva, Pedro Fonseca, João Sousa, Fernando Silva, et al.

    Introduction Cerebral venous and sinus thrombosis (CVST) is a life-threatening disorder which can present with papilledema. Idiopathic intracranial hypertension (IIH) also presents with papilledema, but is a relatively benign condition. Despite often presenting in a similar manner, CVST and IIH may lead to markedly different outcomes. We investigated if papilledema severity, related clinical features, and paraclinical visual assessment, can be used to differentiate between CVST and IIH-related papilledema, this way trying to improve a priori probability for both conditions at the bedside. Methods Consecutive CVST and IIH ambulant alert patients presenting with papilledema were enrolled. Clinical and paraclinical (optical coherence tomography, automated perimetry) data were compared between groups. Results Twelve out of 39 CVST and 34 IIH patients were recruited (males: 2 [CVT], 8 [IIH]; mean age: 40,8 [CVST], 34,1 years [IIH] [p = 0,249]). CVST patients presented with lower papilledema Frisén grade (p = 0.036 OD, p = 0.013 OS), more headache (p = 0.017), shorter headache duration (p = 0.000), and less scotomas on the Amsler grid (p = 0.047). Diplopia was only present in IIH group (n = 7) and additional focal neurological signs were only present in CVST group (n = 5). The CVST group further showed lower peripapillary retinal nerve fiber layer (RNFL) thickness (p = 0.03 OD, p = 0.04 OS), and near significantly lower perimetric mean deviation ((p = 0,058 OD, 0,06 OS). Time to observation, RNFL thickness, and Frisén grade showed area under curve values > 0.76 for distinguishing CVST versus IIH. (0.904, 0.822, 0.761, respectively) Conclusions Combined clinical and paraclinical visual assessment can help to distinguish between CVST- vs. IIH-related papilledema at the bedside.

  • Clinical Reasoning: A 35-Year-Old Woman With Personality Change and Gait Impairment

    by Catarina Bernardes, Tiago Proença dos Santos, João M. Lemos, Gustavo C. Santo

  • Hyperactive Otolith-Ocular Reflex During Heat Tilt (Rabbit’s Eye Sign) In Anti-Ma2 Rhombencephalitis

    by João Lemos, Sara Matos, Ana Inês Martins, João Durães, Alexandre Dionísio, Egídio Machado, André Jorge

    Otolith-ocular reflex (OOR) (contralateral ocular torsion [ocular counter-roll, OCR] and skew deviation [upward deviation of the lowermost eye and/or downward deviation of the uppermost eye]), helps to maintain eye position and stabilize fixation in response to head and/or body tilt in the roll plane. While prominent in lateral-eyed animals, OOR is vestigial in humans, indicating the frontal-eyed system has evolved to inhibit this reflex. We show that OOR can be released under pathological conditions. We describe a patient with anti-Ma2-associated rhombencephalitis manifesting with hyperactive OOR, suggesting cerebellar inhibition failure over OOR brainstem machinery. A 38-year-old male presented with a 6-month history of vertical binocular diplopia exclusively elicited during head tilt to the sides, and difficulty looking down. During head tilts, there was marked OCR in both eyes and prominent hyperdeviation of the lowermost eye. There was additional supranuclear vertical saccadic palsy. Brain MRI showed mild midbrain atrophy. There were high titers of anti-Ma2 antibodies both in serum and CSF, linked to the presence of a mediastinal seminoma. Treatment with anti-inflammatory drugs was ineffective, and tumor-directed therapy was further planned. Hyperactive otolith-ocular reflex (rabbit’s eye sign) is a unique finding in humans. Its presence warrants the investigation of cerebellar/brainstem disease.

  • Vestibular Phenotype–Genotype Correlation in a Cohort of 35 European Usher Syndrome Patients

    by Ana Margarida Amorim, Ana Beatriz Ramada, Ana Cristina Lopes, Hugo Barcelos Figueiredo, João Lemos, João Carlos Ribeiro

    Purpose: The aim of the study was to investigate genotype–phenotype correlations in Usher syndrome (USH). Method: Thirty-five USH patients were included, categorized into three genetic-based groups: USH1 ( n = 11), USH2 ( n = 22), and USH4 ( n = 2). The functional and emotional impact of dizziness and equilibrium was assessed using the Dizziness Handicap Inventory (DHI), the Hospital Anxiety and Depression Scale (HADS), and the Activities-Specific Balance Confidence (ABC) Scale. Participants underwent pure-tone threshold testing, bithermal caloric testing, rotary chair testing (RCT), video head impulse test (vHIT), ocular (oVEMP) and cervical (cVEMP) vestibular evoked myogenic potentials, and posturography. Genotype–phenotype associations were analyzed. Results: Total DHI could only distinguish USH1 (25.71 ± 21.04) from USH2 (50.13 ± 22.54, p = .024) but not between the three groups ( p = .084). ABC and HADS could not also distinguish between the three USH subgroups ( p = .286 and .180). Hearing loss in USH1 was significantly greater than in USH2 and USH4 ( p < .001). USH1 showed greater caloric weakness than USH2 and USH4 ( p < .004). RCT was not completed in USH4 but could distinguish between USH1 and USH2 (sinus 0.16 Hz, p = .033; sinus 0.32 Hz, p = .011; and sinus 0.64 Hz, p = .003). vHIT in USH1 demonstrated lower overall gain than in USH2 and USH4 ( p < .001). USH1 showed higher number of absent cVEMP responses in the right and/or left ear when compared to USH2/USH4 ( p < .001). USH1 showed a higher number of absent oVEMP responses in the right and/or left ear when compared to USH2 and USH4 (right ear, p < .007; left ear, p < .023). In posturography, no relevant differences were found between the three USH groups. Conclusions: Contemporary hearing and vestibular assessment successfully differentiated between distinct USH groups. However, varying degrees of vestibular dysfunction were observed across all groups.


  • Ocular Neuromyotonia in Thyroid Eye Disease

    by André Sobral-Pinho, Diana Festas Silva, Daniela Pereira, Sara Matos, Ana Inês Martins, André Jorge, Guilherme Castela, João Lemos

    Ocular neuromyotonia (ONM) in thyroid eye disease (TED) seems to be a rare finding. We present the case of a 61-year-old male TED patient who developed spontaneous transient neuromyotonic infradeviation of the right eye every ~1 minute in the setting of prominent enlargement of the right inferior rectus muscle and restriction of supraduction. Neither carbamazepine or lacosamide were able to abate ONM. Following subsequent TED worsening with almost complete restriction of the right eye, ONM was no longer observed. ONM has been described in 7 TED cases, either in conjunction with underlying restrictive strabismus or in isolation. Chronic compression and inflammation seem to lead to nerve hyperirritability, demyelination, and/or axonal damage and predispose to ONM in TED. Importantly, ONM might develop during active or inactive TED. Voltage gated sodium channel blockers should be used in TED-related ONM, albeit clinical response might be incomplete, suggesting the presence of other mechanism(s), besides ephaptic transmission. Newer neuronal membrane stabilizers acting on sodium and calcium channels (e.g. lamotrigine, oxcarbazepine) as well as newer monoclonal antibodies (e.g. teprotumumab, tocilizumab, infliximab) might play a role in TED-related ONM and their potential therapeutic effect should be investigated in future studies.

  • The Clinical Use of Retinotopy in Functional Hemianopia

    by Roberto Mendes Franco, Otília C. D’ALmeida, Miguel Raimundo, Pedro Fonseca, Sara Matos, Ana Inês Martins, André Jorge, Daniela Pereira, Miguel Castelo-Branco, João Lemos

    Functional visual loss (FVL), like other subtypes of functional neurological-psychiatric disorders, refers to the subjective experience of visual impairment despite evidence demonstrating structura...

  • Clinical Reasoning: A 35-Year-Old Woman With Personality Change and Gait Impairment

    by Catarina Bernardes, Tiago Proença dos Santos, João M. Lemos, Gustavo C. Santo

    A 35-year-old woman presented with a progressive 3-year history of personality changes and gait impairment. Neurologic examination revealed bilateral optic atrophy, spastic paraparesis, and impaired vibratory sensation in all limbs, and neuropsychological evaluation identified a frontotemporal cognitive impairment. In this article, we review the differential diagnosis for a young woman with chronic frontotemporal dysfunction, optic atrophy, and dorsolateral myelopathy in a stepwise multidisciplinary approach. Critical information obtained from the medical history led to a final diagnosis.


  • Otolith function in Usher type II syndrome

    by Ana Margarida Amorim, Diliana Rebelo, Ana Beatriz Ramada, Ana Cristina Lopes, João Lemos, João Carlos Ribeiro

    Usher's syndrome type II (USH2) is a rare genetic disorder encompassing hearing loss, vision impairment, and apparent intact vestibular function. Recent research suggests a potential involvement of the otolith vestibular receptors in USH2. Evaluate otolith dynamic function in USH2. Twenty-two USH2 (median age 53.9 ± 2.99) and age-matched controls underwent a complete battery vestibular testing including air conducted cervical and ocular vestibular evoked myogenic potentials (c-VEMPs and o-VEMPs). Vestibular function tests were correlated with Activities Balance Scale (ABC) and Dizziness Handicap Inventory (DHI) scores. Fourteen USH2 reported previous vertigo (vs none control). Among 88 ears, c-VEMPs were absent in 15 USH2 cases and 4 controls (p = 0.034), while o-VEMPs were absent in 22 USH2 cases and 12 controls (p = 0.129). There were significant differences between USH2 vs controls in right ear o-VEMP N1 latencies (median 11.60/10.40, p < 0.010), N1-P1 amplitudes (median 5.15/10.10, p < 0.003) and in o-VEMP N1-P1 asymmetry ratio (median 24.78/40.50, p < 0.014). USH2 showed a strong correlation between o-VEMP amplitude and DHI score (p = 0.003, ρ = 0.769). No association was found between vertigo and VEMPs subgroups. Our findings suggest the presence of otolith dysfunction in USH2, which is independent from subjectively reported dizziness. Incorporating vestibular testing into USH2 evaluation and monitoring could enhance characterization of this multisensory disease.


  • Isolated Ptosis as the Single Clinical Manifestation of Anti-Myelin Oligodendrocyte Glycoprotein Syndrome

    by Beatriz Madureira, Sara Matos, André Jorge, Inês Ot Pais, Rui Pedro Pais, Inês Correia, Ana Inês Martins, João Lemos